My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
August 2008
Vol. 18 No. 8
Drug Approvals, Recalls, Adverse Events Update

The Food and Drug Administration (FDA) recently approved changes to the package insert for Ziagen (abacavir sulfate) highlighting information about the association of the HLA-B*5701 allele and hypersensitivity reactions caused by abacavir-containing therapy. 

For urgent clinical updates from the Centers for Disease Control and Prevention (CDC) and FDA, IDSA offers two e-mail services to help members stay informed.  IDSA members can sign up for this service online. (You must be logged in to have access to this link.)

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Flu Vaccine Begins Shipping
IDSA Journal Club, August 2008
IDSA News CORRECTION
In the IDSA Journals
EIN: Alternative Dosages for Clinamycin
Drug Approvals, Recalls, Adverse Events Update
Medicare Adds Only One New HAC to the List for Nonpayment in 2009
Plan Your ICAAC/IDSA Conference with the Online Program Planner
IDSA Advocacy Update: Animal Drug Legislation Passes
Applications Being Accepted for Lyme Disease Review Panel
Vote for the IDSA Board of Directors
Members on the Move
Welcome, New IDSA Members!

  

 

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.